OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
mRNA Vaccine - A New Cancer Treatment Strategy
Tian Tan, Shuting Deng, Bing-Huo Wu, et al.
Current Cancer Drug Targets (2023) Vol. 23, Iss. 9, pp. 669-681
Closed Access | Times Cited: 16
Tian Tan, Shuting Deng, Bing-Huo Wu, et al.
Current Cancer Drug Targets (2023) Vol. 23, Iss. 9, pp. 669-681
Closed Access | Times Cited: 16
Showing 16 citing articles:
Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities
Bolin Wang, Jinli Pei, Shengnan Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 66
Bolin Wang, Jinli Pei, Shengnan Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 66
Advances in mRNA-Based Cancer Vaccines
Ling Ni
Vaccines (2023) Vol. 11, Iss. 10, pp. 1599-1599
Open Access | Times Cited: 24
Ling Ni
Vaccines (2023) Vol. 11, Iss. 10, pp. 1599-1599
Open Access | Times Cited: 24
Research progress on the quality control of mRNA vaccines
Chaoying Hu, Yu Bai, Jianyang Liu, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 570-583
Open Access | Times Cited: 10
Chaoying Hu, Yu Bai, Jianyang Liu, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 570-583
Open Access | Times Cited: 10
Nucleic acid cancer vaccines targeting tumor related angiogenesis. Could mRNA vaccines constitute a game changer?
Srdan Tadic, Alfredo Martı́nez
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Srdan Tadic, Alfredo Martı́nez
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
mRNA vaccines in the context of cancer treatment: from concept to application
Qiang Fu, Xiaoming Zhao, Jinxia Hu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Qiang Fu, Xiaoming Zhao, Jinxia Hu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Nucleic acid vaccines‐based therapy for triple‐negative breast cancer: A new paradigm in tumor immunotherapy arena
Raed Obaid Saleh, Fatma M. Ibrahim, Harikumar Pallathadka, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 3
Closed Access | Times Cited: 4
Raed Obaid Saleh, Fatma M. Ibrahim, Harikumar Pallathadka, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 3
Closed Access | Times Cited: 4
Immunocyte membrane-derived biomimetic nano-drug delivery system: a pioneering platform for tumour immunotherapy
Y Zeng, Qing Gu, Dan Li, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 12, pp. 2455-2473
Closed Access | Times Cited: 4
Y Zeng, Qing Gu, Dan Li, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 12, pp. 2455-2473
Closed Access | Times Cited: 4
Protective immunity induced by a novel P1 adhesin C-terminal anchored mRNA vaccine against Mycoplasma pneumoniae infection in BALB/c mice
Qilin Zeng, Peiyuan Sun, Weiwei Li, et al.
Microbiology Spectrum (2025)
Open Access
Qilin Zeng, Peiyuan Sun, Weiwei Li, et al.
Microbiology Spectrum (2025)
Open Access
mRNA vaccine in gastrointestinal tumors: Immunomodulatory effects and immunotherapy
Ao Zhang, Qingming Ji, Xia Sheng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115361-115361
Open Access | Times Cited: 9
Ao Zhang, Qingming Ji, Xia Sheng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115361-115361
Open Access | Times Cited: 9
mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy
Alireza Shariati, Pouria Khani, Farzad Nasri, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Alireza Shariati, Pouria Khani, Farzad Nasri, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Bibliometric analysis of RNA vaccines for cancer
Yang Xue, Jian Kang, Zhaohui Xing, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 4
Yang Xue, Jian Kang, Zhaohui Xing, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 4
Identification of immunity- and ferroptosis-related signature genes as potential design targets for mRNA vaccines in AML patients
Chaojie Wang, Liping Lv, Ping Ma, et al.
Aging (2024) Vol. 16, Iss. 16, pp. 11939-11954
Open Access
Chaojie Wang, Liping Lv, Ping Ma, et al.
Aging (2024) Vol. 16, Iss. 16, pp. 11939-11954
Open Access
Innovations in mRNA-based cancer immunotherapy: Challenges and future directions
Matthew Essuah, Buniechukwuenu Emmanuel Mbamalu, Ridwan Ayodele Akanmu, et al.
World Journal of Biology Pharmacy and Health Sciences (2024) Vol. 20, Iss. 2, pp. 702-724
Open Access
Matthew Essuah, Buniechukwuenu Emmanuel Mbamalu, Ridwan Ayodele Akanmu, et al.
World Journal of Biology Pharmacy and Health Sciences (2024) Vol. 20, Iss. 2, pp. 702-724
Open Access
Therapeutic mRNAs for cancer immunotherapy: From structure to delivery
Monika Vishwakarma, Wasim Akram, Tanweer Haider
Advances in immunology (2024)
Closed Access
Monika Vishwakarma, Wasim Akram, Tanweer Haider
Advances in immunology (2024)
Closed Access
An antibody-free evaluation of an mRNA COVID-19 vaccine
Paul J. Branham, Hans C. Cooper, Yulanda M. Williamson, et al.
Biologicals (2023) Vol. 85, pp. 101738-101738
Closed Access
Paul J. Branham, Hans C. Cooper, Yulanda M. Williamson, et al.
Biologicals (2023) Vol. 85, pp. 101738-101738
Closed Access
Application of mRNA Vaccines in HCC Treatment
Rui Han
SciBase clinical and medical case reports. (2023) Vol. 1, Iss. 3
Open Access
Rui Han
SciBase clinical and medical case reports. (2023) Vol. 1, Iss. 3
Open Access
